CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Clinical trial NCT03163667 · COMPLETED

Trial details

NCT number: NCT03163667
Sponsor: Calithera Biosciences, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2017-09-06
Primary completion: 2019-04-26
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.